Modeling the Complete Dynamics of the SARS-CoV-2 Pandemic of Germany and Its Federal States Using Multiple Levels of Data.

Publication date: Jul 14, 2025

Background/Objectives: Epidemiological modeling is a vital tool for managing pandemics, including SARS-CoV-2. Advances in the understanding of epidemiological dynamics and access to new data sources necessitate ongoing adjustments to modeling techniques. In this study, we present a significantly expanded and updated version of our previous SARS-CoV-2 model formulated as input-output non-linear dynamical systems (IO-NLDS). Methods: This updated framework incorporates age-dependent contact patterns, immune waning, and new data sources, including seropositivity studies, hospital dynamics, variant trends, the effects of non-pharmaceutical interventions, and the dynamics of vaccination campaigns. Results: We analyze the dynamics of various datasets spanning the entire pandemic in Germany and its 16 federal states using this model. This analysis enables us to explore the regional heterogeneity of model parameters across Germany for the first time. We enhance our estimation methodology by introducing constraints on parameter variation among federal states to achieve this. This enables us to reliably estimate thousands of parameters based on hundreds of thousands of data points. Conclusions: Our approach is adaptable to other epidemic scenarios and even different domains, contributing to broader pandemic preparedness efforts.

Open Access PDF

Concepts Keywords
Expanded Bayesian knowledge synthesis
Germany COVID-19
Pandemic COVID-19
Studies dark figure
Vaccination Epidemiological Models
Germany
Humans
machine learning
pandemic preparedness
Pandemics
parameter heterogeneity
parametrization
SARS-CoV-2
SARS-CoV-2 epidemiologic models

Semantics

Type Source Name
disease MESH data sources
disease MESH COVID 19
disease MESH lung diseases
disease MESH infection
disease MESH uncertainty
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH Death
drug DRUGBANK Coenzyme M
disease MESH Emergency
disease MESH privacy
disease IDO algorithm
disease IDO process
disease IDO infectivity
disease MESH re infection
disease IDO susceptibility
disease IDO history
drug DRUGBANK Huperzine B
disease IDO replication
pathway REACTOME Translation
disease IDO contact tracing
drug DRUGBANK (S)-Des-Me-Ampa
pathway REACTOME Reproduction
disease MESH infectious diseases
drug DRUGBANK Haloperidol
disease IDO symptom
disease IDO contagiousness
disease MESH Coronavirus Infections
drug DRUGBANK Guanosine
pathway REACTOME Immune System

Original Article

(Visited 6 times, 1 visits today)